Результаты поиска

Survival of hematological patients after discharge from the intensive care unit: a prospective observational study.

IntroductionAlthough the survival rates of hematological patients admitted to the ICU are improving, little is known about the long-term outcome. Our objective was to identify factors related to long-term outcome in hematological patients after ICU discharge.MethodsA prospective, observational study was carried out in seven centers in Spain. From an initial sample of 161 hematological patients admitted to one of the participating ICUs during the study period, 62 were discharged alive and followed for a median time of 23 (1 to 54) months. Univariate and multivariate analysis were performed to i

Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008.

BackgroundThe nationwide statistical analysis of hematologic malignancies in Korea has not been reported yet.MethodsThe Korea Central Cancer Registry and the Korean Society of Hematology jointly investigated domestic incidence rates and prevalence of hematologic malignancies occurred between 1999 and 2008, and analyzed survival rates of patients who were diagnosed between 1993 and 2008. Data of hematologic malignancies from 1993 to 2008 were obtained from the Korean National Cancer Incidence Data base. The crude incidence rates, age-specific incidence rates, age-standardized incidence rates, a

Исключительные долгосрочные ответные меры, принятые в ходе испытаний ОКЕАН и ГОРИЗОН: мелфлюфен-дексаметасон в качестве расширения возможностей лечения повторной/нереакторной множественной миеломы в эпоху новой иммунотерапии?

Алкилатные агенты представляют собой первый эффективный класс наркотиков в множестве миеломы (ММ), но после внедрения новых эффективных лекарственных средств их потребление постепенно сокращается и в настоящее время переводится на автологическую трансплантацию стволовых клеток (ASCT) и несколько других объектов. Тем не менее, США одобрили комбинацию мелфлюфена (пиптидно-наркотика, про-наркотика мелфалана) и дексаметасона. Управление по контролю за продуктами питания и лекарственными препаратами (УПП) для пациентов с трехклассными отклонениями после ≥ 4 :: предыдущая терапия (ЛОТ) по результата

Pre-transplant depression decreased overall survival of patients receiving allogeneic hematopoietic stem cell transplantation: a nationwide cohort study.

Studies investigating association of depression with overall survival (OS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) yielded conflicting results. A nationwide cohort study, which included all adult patients [n = 7,170; depression group, 13.3% (N = 956); non-depression group, 86.7% (N = 6,214)] who received allo-HSCT from 2002 to 2018 in South Korea, analyzed risk of pre-transplant depression in OS of allo-HSCT. Subjects were followed from the day they received allo-HSCT, to occurrence of death, or last follow-up day (December 31, 2018). Median age at allo-HSCT for de

Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Myeloproliferative neoplasms (MPNs) are unique hematopoietic stem cell disorders sharing mutations that constitutively activate the signal-transduction pathways involved in haematopoiesis. They are characterized by stem cell-derived clonal myeloproliferation. The key MPNs comprise chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). CML is defined by the presence of the Philadelphia (Ph) chromosome and BCR-ABL1 fusion gene. Despite effective cytoreductive agents and targeted therapy, complete CML/MPN stem cell eradication is r

Localized fungal osteomyelitis caused by Aspergillus sp. in the ilium and acetabulum of a dog with disseminated aspergillosis: A case report.

BACKGROUND: Osteomyelitis caused by Aspergillus sp. is uncommon in dogs and cats and may occur in cases of disseminated aspergillosis, a rare and poorly described condition in veterinary medicine. CASE DESCRIPTION: Due to the scarcity of reports documenting this disease, particularly with localized involvement of the pelvic bones, the present case report aimed to describe the condition in an 8-year-old mixed-breed dog presenting with severe pain and lameness of the right pelvic limb. Radiographic examination revealed marked periosteal bone proliferation and osteolysis extending from the right

Воспаление и иммунная микроокружающая среда в миелопролазерных неоплазмах: патогенные механизмы и терапевтические возможности.

Филадельфия-отрицательная (Ph-отрицательная) миелопролиферативные новообразования (MPNs) включают полицифемию (PV), основную тромбоцитемию (ET) и первичный миэлофиброз (PMF), которые являются клональными гематопоэтическими расстройствами, вызванными соматическими генными мутациями в генах JAK2, CALR или MPL. Мутации активируют путь JAK-STAT и прерывают сигнализацию NF-IB, что приводит к хроническому подстрекательству, вызванному провоспалительными цитокинами и реактивными видами кислорода (ROS). Эта изменившаяся микроокружающая среда вызывает серьезные клинические особенности заболевания, таки

Совпадение в полном тексте источника
… Specifically, myeloid-derived suppressor cells (MDSCs) may constitute an essential connection between inflammation and the suppression of antitumor T cell immunity; they have previously demonstrated significant activity in several hematologic neoplasms. … This discovery is consistent with previous studies on TAMs in hematological neoplasms, for instance, acute leukemias and lymphoma. Notably, TAMs can impair the activity of CD4+ and CD8+ T cells by producing immunosuppressive substances. …

Нынешний подход к решению проблемы вторичного недоедания у пациентов с гематологическими отклонениями: рекомендации в отношении консенсуса экспертов Испании.

Для оценки мнений клинических гематологов было проведено обследование на базе Делфи (n = 17) и клинических иммунологов (n = 18) по всей Испании о вторичных иммунодефицитах (СИД) в области лечения онкогематологических пациентов. Там было 100% :: согласие с необходимостью наличия руководящих принципов в отношении лечения иммунодефицита у пациентов, страдающих гематологией; проведение базовой иммунологической оценки у пациентов с хронической лимфоцитной лейкемией (КЛЛ), множественной миеломой (ММ), лимфомой и гематопоиетической трансплантацией стволовых клеток (ХСБТ); и количественная оценка уров

Совпадение в полном тексте источника
… neoplasms and SID | 100 0–10 patients/year | 9 10–20 patients/year | 32 Overall, 54% of participants reported more than 15 years of professional experience and 29% had between 5 and 10 years. … Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic Defects. Clin. Infect. Dis. 2011;53:798–806. doi: 10.1093/cid/cir492. 27. Friman V., Winqvist O., Blimark C., Langerbeins P., Chapel H., Dhalla F. …

The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms.

Nucleotide-binding domain (NOD)-like receptor protein 3 (NLRP3) is the most widely investigated inflammasome member whose overactivation can be a driver of several carcinomas. It is activated in response to different signals and plays an important role in metabolic disorders and inflammatory and autoimmune diseases. NLRP3 belongs to the pattern recognition receptors (PRRs) family, expressed in numerous immune cells, and it plays its primary function in myeloid cells. NLRP3 has a crucial role in myeloproliferative neoplasms (MPNs), considered to be the diseases best studied in the inflammasome

The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.

BackgroundClinical outcomes of novel coronavirus 2019 disease (COVID-19) in onco-hematological patients are unknown. When compared to non-immunocompromised patients, onco-hematological patients seem to have higher mortality rates.AimsWe describe the characteristics and outcomes of a consecutive cohort of 24 onco-hematological patients with COVID-19 during the first month of the pandemic. We also describe variations in healthcare resource utilization within our hematology department.Methods and resultsData from patients between the first month of the pandemic were retrospectively collected. Cli

Совпадение в полном тексте источника
… The primary endpoint of the study was to describe the all‐cause in‐hospital mortality rate in patients with hematologic neoplasms and a confirmed diagnosis of COVID19 infection, defined as the proportion of patients with COVID‐19 who died to the overall cohort. … We believe that the high mortality rate cannot be attributed exclusively to the COVID19, especially considering that 20/24 patients (83%) had an active underlying hematological neoplasm. …

Artificial inteligence and datasets for leukemia diagnosis: A scoping review of machine lerning and deep learning approaches.

Leukemia is the cancerous disease of the blood and the bone marrow that causes excessive proliferation of abnormal white blood cells, if detected too late, it can lead to potentially fatal consequences. Peripheral blood smear examinations and bone marrow biopsy are example of conventional diagnostic techniques that are invasive, time-consuming and subject to human variability. Recent advances in artificial intelligence (AI) particularly in the areas of Machine Learning (ML) and Deep Learning (DL)offer encouraging answers by making it possible to detect and classify leukemia using automated, ef

Expert Perspective: Hematologic Malignancies and Vasculitis.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case report.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?

The current pandemic coronavirus, SARS-CoV-2, is known to cause severe infection (COVID-19) in patients with comorbidities, particularly cancer or an immunosuppressed state. Most healthcare systems in the country are likely to be overwhelmed soon if the pandemic moves to a stage of community transmission. Currently, limited evidence is available for managing patients with hematological disorders during the COVID-19 pandemic. The current review summarises the possible challenges clinicians are likely to face, key considerations to guide decision making, and possible solutions to the anticipated

Effects of nurse-led symptom management in chronic myeloid malignancies: a randomized trial.

PurposeChronic hematological malignancies progress slowly, potentially manifesting symptoms spanning months to years. HM-PRO is developed as a comprehensive clinical tool for assessing symptoms in hematology. The aim was to investigate the effect of a nurse-led systematic approach to symptom identification and management using HM-PRO in outpatient care in patients with chronic hematological malignancies.MethodsThis is a randomized trial including 94 patients to investigate an intervention comprising (1) HM-PRO data collection, (2) HM-PRO assessment guided by an algorithm, and (3) nurse-led tai

Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers.

Mesenchymal stromal cells (MSCs) are a subset of heterogeneous, non-hematopoietic fibroblast-like cells which play important roles in tissue repair, inflammation, and immune modulation. MSCs residing in the bone marrow microenvironment (BMME) functionally interact with hematopoietic stem progenitor cells regulating hematopoiesis. However, MSCs have also emerged in recent years as key regulators of the tumor microenvironment. Indeed, they are now considered active players in the pathophysiology of hematologic malignancies rather than passive bystanders in the hematopoietic microenvironment. Onc

Искусственный интеллект, видоизменяющий парадигму гематологического диагноза и лечения злокачественных заболеваний: от статической оценки до динамического управления точностью.

Искусственный интеллект (ИИ) все чаще изучается в качестве инструмента содействия более точному и динамичному управлению диагностикой и лечением гематологов. В отличие от предыдущих обзоров, в которых основное внимание уделялось отдельным типам заболеваний или изолированным технологическим путям, в настоящем документе содержится всеобъемлющий обзор текущих прикладных программ АИШ и последних достижений в области диагностики, классификации, оценки прогнозов и принятия решений по лечению лейкемии, лимфомы, множественной миэломы и миэлодиспластических синдромов. Она охватывает ключевые технически

Efficacy and safety of chimeric antigen receptor T-cell in the treatment of hematologic malignancy: an umbrella review of systematic review and meta-analysis.

BACKGROUND: This umbrella review consolidates data from systematic reviews and meta-analyses on the efficacy and safety of Chimeric Antigen Receptor T-cell (CAR-T) therapy in hematologic malignancies. The aim is to assess CAR-T efficacy across different malignancies, identify key safety concerns, and provide clinical recommendations. METHODS: We conducted a thorough search of PubMed, Embase, Web of Science, and the Cochrane Database of Systematic Reviews up to May 2024. Systematic reviews and meta-analyses evaluating CAR-T efficacy in hematologic malignancies were included. The AMSTAR tool wa

Psychological distress, chronic conditions and quality of life in elderly hematologic cancer patients: study protocol of a prospective study.

BackgroundSimilar to most solid tumors, the incidence of hematologic malignancies has been rising. Although the median age at diagnosis is about 70 years, little is known about psychosocial aspects and comorbid conditions in elderly patients with hematologic cancers. The main objectives of our study are to assess the prevalence of psychological distress, chronic conditions, functional disabilities, and quality of life in both elderly hematologic cancer patients aged ≥70 years and an age-matched comparison sample of the general population.MethodsWe conduct a prospective study with three measuri

Short and long term central peripherally inserted catheters in hematological malignancy patients: clinical outcomes and safety. Single centre experience.

ObjectiveTo characterise the population and describe the complications in patients with hematologic malignancies who underwent implantation of a peripherally inserted central catheter (PICC) or midline catheter (MC) for the administration of chemotherapy or oncologic support.MethodsThe retrospective descriptive study included patients with hematologic malignancies who underwent PICC or MC implantation between July 2022 and 2024. All patients are part of the institution-based prospective observational Evidence - Verification - Analysis study. Variables related to device type were obtained from

Совпадение в полном тексте источника
… The best available information for using PICCs in chemotherapy treatment is provided by The Cancer and Venous Access trial, which included more than 1,000 patients with solid tumours or hematologic neoplasms who underwent placement of tunneled catheters, PICCs or totally implanted PORTs. … However, it is noteworthy that only 11% of the patients represented in this study had hematological neoplasms. These results highlight the importance of evaluating the exclusive use of these devices in this specific population. …